Orgiazzi J
Department of Endocrinology, Centre Hospitalier Lyon Sud, France.
Endocrinol Metab Clin North Am. 2000 Jun;29(2):339-55, vii. doi: 10.1016/s0889-8529(05)70135-3.
Anti-thyroid stimulating hormone receptor antibodies are pathophysiologic and clinical indicators in autoimmune thyroid diseases, not only in Graves' disease. The detection of these antibodies is useful for diagnostic and management purposes. The presence and titers of anti-TSH receptor antibodies, however, have to be interpreted in light of the clinical and other biological characteristics of each patient. Newer, more sensitive assays of anti-TSH receptor antibodies may increase their significance in the diagnosis and management of autoimmune thyroid diseases and Graves' disease.
抗促甲状腺激素受体抗体不仅是格雷夫斯病,也是自身免疫性甲状腺疾病的病理生理和临床指标。检测这些抗体对诊断和治疗具有重要意义。然而,抗促甲状腺激素受体抗体的存在及滴度必须结合每个患者的临床和其他生物学特征来解读。更新、更敏感的抗促甲状腺激素受体抗体检测方法可能会提高其在自身免疫性甲状腺疾病和格雷夫斯病诊断及治疗中的重要性。